$4.68
0.010.21%
At close: Jul 17, 5:00 PM EST
$4.68
N/A
After Hours: Jul 17, 4:01 PM EST
AN2 Therapeutics Inc Earnings Estimates
ANTXNASDAQ
AN2 Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ANTX
AN2 Therapeutics (ANTX) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.23 and quarterly revenue of N/A.
In the most recent quarter (Q1), AN2 Therapeutics reported EPS of $-0.29, missing estimates of $-0.23 by 0.26%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
AN2 Therapeutics has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, AN2 Therapeutics has averaged an EPS surprise of 0.30% and a revenue surprise of 0.00%.
Earnings Date
Aug 11
EPS Estimate
$-0.230
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
AN2 Therapeutics Earnings History
Analyze the earnings history of AN2 Therapeutics using advanced sorting and filters.
Loading calendar...
AN2 Therapeutics (ANTX) Earnings Per Share
The chart below shows AN2 Therapeutics's reported EPS compared to analyst estimates over recent quarters.
AN2 Therapeutics (ANTX) Revenue
The chart below shows AN2 Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is AN2 Therapeutics (NASDAQ:ANTX) reporting earnings?
AN2 Therapeutics (ANTX) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 11, 2026 for Q1.
What were the latest earnings per share (EPS) for AN2 Therapeutics (NASDAQ:ANTX)?
The Actual EPS was $-0.29, which missed the estimate of $-0.23.
What were AN2 Therapeutics’s (NASDAQ:ANTX) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
